(Q36133813)

12 August 2017

1 reference

title

Social anxiety disorder : current treatment recommendations (English)

1 reference

12 August 2017

social anxiety disorder

1 reference

4

1 reference

Jacqueline Müller-Nordhorn

12 August 2017

3

Soraya Seedat

0 references

series ordinal

1

object named as

Jacqueline E Muller

1 reference

12 August 2017

2

Liezl Koen

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

19

1 reference

12 August 2017

377-391

1 reference

12 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200519050-00002

12 August 2017

0 references

cites work

Bupropion-SR in treatment of social phobia

1 reference

12 December 2020

The role of selective serotonin reuptake inhibitors in reducing alcohol consumption

1 reference

12 December 2020

Treatment of anxiety disorders to remission.

1 reference

12 December 2020

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

1 reference

12 December 2020

Tranylcypromine in social phobia.

1 reference

12 December 2020

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine

1 reference

12 December 2020

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

12 December 2020

Phenelzine efficacy in refractory social anxiety disorder: a case series

1 reference

12 December 2020

Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study

1 reference

12 December 2020

1 reference

12 December 2020

Phobia: prevalence and risk factors

1 reference

12 December 2020

Non-pharmacologic treatments for social anxiety disorder

1 reference

12 December 2020

Placebo-controlled trial of moclobemide in social phobia

1 reference

12 December 2020

Social anxiety disorder: designing a pharmacologic treatment strategy

1 reference

12 December 2020

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

12 December 2020

Effect of beta blockade on singing performance

1 reference

12 December 2020

Effects of positive GABA(A) modulators on a multiple-component, repeated-acquisition test of spatial learning

1 reference

12 December 2020

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study

1 reference

12 December 2020

The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation

1 reference

12 December 2020

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder

1 reference

12 December 2020

Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions

1 reference

12 December 2020

Social phobia. Comorbidity and morbidity in an epidemiologic sample

1 reference

12 December 2020

Effect of pindolol on stress-related disturbances of musical performance: preliminary communication

1 reference

12 December 2020

The Zurich study. XX. Social phobia and agoraphobia.

1 reference

12 December 2020

Buspirone in social phobia.

1 reference

12 December 2020

Pharmacological treatment of social anxiety disorder: a meta-analysis

1 reference

12 December 2020

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

12 December 2020

Phenelzine v imipramine in atypical depression. A preliminary report

1 reference

12 December 2020

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

12 December 2020

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder

1 reference

12 December 2020

Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale

1 reference

12 December 2020

Social phobia subtypes in the National Comorbidity Survey.

1 reference

12 December 2020

Dismantling cognitive-behavioral group therapy for social phobia.

1 reference

12 December 2020

Effect of oxprenolol on stage-fright in musicians

1 reference

12 December 2020

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1 reference

12 December 2020

Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

1 reference

12 December 2020

Efficacy of olanzapine in social anxiety disorder: a pilot study

1 reference

12 December 2020

A large open multicentre trial of clomipramine (Anafranil) in the management of phobic disorders

1 reference

12 December 2020

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

1 reference

12 December 2020

Paroxetine for social anxiety and alcohol use in dual-diagnosed patients

1 reference

12 December 2020

Venlafaxine in social phobia.

1 reference

12 December 2020

Stage Fright in Musicians: A Model Illustrating the Effect of Beta Blockers

1 reference

12 December 2020

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

1 reference

12 December 2020

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial

1 reference

12 December 2020

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

1 reference

12 December 2020

The assessment of anxiety states by rating

1 reference

12 December 2020

Scrutinizing the relationship between shyness and social phobia.

1 reference

12 December 2020

The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

State-dependent effects of atypical benzodiazepine-receptor agonists.

1 reference

12 December 2020

Psychological and pharmacological treatments of social phobia: a meta-analysis

1 reference

12 December 2020

Pharmacotherapy of social anxiety disorder

1 reference

12 December 2020

Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial

1 reference

12 December 2020

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

12 December 2020

Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders

1 reference

12 December 2020

Sertraline in children and adolescents with social anxiety disorder: an open trial

1 reference

12 December 2020

Mini-SPIN: A brief screening assessment for generalized social anxiety disorder

1 reference

12 December 2020

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

1 reference

12 December 2020

Antidepressant specificity in atypical depression.

1 reference

12 December 2020

Citalopram treatment of social anxiety disorder with comorbid major depression

1 reference

12 December 2020

Treatment of social phobia with clonazepam and placebo.

1 reference

12 December 2020

Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients

1 reference

12 December 2020

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

12 December 2020

Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome

1 reference

12 December 2020

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

12 December 2020

Meta-analysis of cognitive-behavioral treatments for social phobia

1 reference

12 December 2020

Effect of beta-blockade during bowling competitions

1 reference

12 December 2020

An open clinical trial of reboxetine in the treatment of social phobia

1 reference

12 December 2020

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

12 December 2020

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

1 reference

12 December 2020

Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey

1 reference

12 December 2020

Hepatic adverse reactions associated with nefazodone

1 reference

12 December 2020

Physical disability and social phobia

1 reference

12 December 2020

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

12 December 2020

The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study

1 reference

12 December 2020

Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial

1 reference

12 December 2020

Effectiveness of an empirically supported treatment for social phobia in the field.

1 reference

12 December 2020

Moclobemide in social phobia: a controlled dose-response trial

1 reference

12 December 2020

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

12 December 2020

Behavioral treatment of childhood social phobia

1 reference

12 December 2020

Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy

1 reference

12 December 2020

A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).

1 reference

12 December 2020

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

12 December 2020

A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care

1 reference

12 December 2020

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

1 reference

12 December 2020

Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.

1 reference

12 December 2020

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

1 reference

12 December 2020

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings

1 reference

12 December 2020

Algorithm for the pharmacotherapy of anxiety disorders.

1 reference

12 December 2020

Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

1 reference

12 December 2020

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

12 December 2020

Social anxiety disorder: an unrecognized problem in primary care

1 reference

12 December 2020

Letter: Beta-blocking agents in the treatment of catecholamine-induced symptoms in musicians

1 reference

12 December 2020

Fluoxetine for the treatment of social phobia

1 reference

12 December 2020

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

12 December 2020

The Brief Social Phobia Scale: a psychometric evaluation.

1 reference

12 December 2020

Nefazodone in social phobia

1 reference

12 December 2020

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study

1 reference

12 December 2020

Low dose selegiline (L-Deprenyl) in social phobia

1 reference

12 December 2020

Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder

1 reference

12 December 2020

Effect of beta blockade and beta stimulation on stage fright

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Pharmacotherapy for social phobia

1 reference

12 December 2020

Open trial of interpersonal psychotherapy for the treatment of social phobia

1 reference

12 December 2020

Hyperhidrosis in social anxiety disorder

1 reference

12 December 2020

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

1 reference

12 December 2020

Imipramine in the treatment of social phobia.

1 reference

12 December 2020

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

1 reference

12 December 2020

Psychometric properties of the Liebowitz Social Anxiety Scale.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

1 reference

12 December 2020

The effect of beta adrenergic blocking drugs on speakers' performance and memory.

1 reference

12 December 2020

Fluoxetine in social phobia

1 reference

12 December 2020

Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity.

1 reference

12 December 2020

10.2165/00023210-200519050-00002

Identifiers

DOI

1 reference

PubMed ID

15907150

Dimensions Publication ID

12 August 2017

0 references

1 reference

PubMed ID

15907150